ReviewArthritis research & therapy2015

Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.

Torsten Lowin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.